Info

Cytori Therapeutics, Inc. develops, manufactures, and sells medical technologies to enable the practice of regenerative medicine. The Company’s commercial activities are focused on reconstructive surgery in Europe and Asia-Pacific, and stem and regenerative cell banking (cell preservation) in Japan. Its product pipeline includes the development of new treatments for cardiovascular disease, orthopedic damage, gastrointestinal disorders, and pelvic health conditions. The Company’s Celution System family of products process patients’ cells at the bedside in real time. Each member of the Celution System family of products consists of a central device, a related single-use consumable used for each patient procedure, and supportive procedural components. The Company’s distribution network covers Belgium, China, Greece, Israel, Italy, Korea, Luxembourg, Malaysia, Portugal, Singapore, Spain, Taiwan and the Netherlands.(Source: 10-K)